Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1996
11/27/1996EP0743858A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
11/27/1996EP0743857A1 Method of making polymers having specific properties
11/27/1996EP0625900B1 Compositions and processes for the sustained release of drugs
11/27/1996EP0621895A4 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway.
11/27/1996EP0618973B1 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY
11/27/1996EP0552243B1 Use of il-4 to treat solid tumors
11/27/1996EP0489839B1 Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/27/1996EP0446361B1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
11/27/1996CN1136826A Recombinant P53 adenovirus method and compositions
11/27/1996CN1136813A Novel synthetic peptide, lung surfactant containing the same and remedy for respiratory distress syndrome
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136779A Long-acting injection suspensions and process for their preparation
11/27/1996CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope
11/27/1996CN1136777A Immunomodulating compositions from bile
11/27/1996CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
11/26/1996US5578718 Thiol-derivatized nucleosides
11/26/1996US5578715 Methods, kits, and probes for diagnosing HIV-2
11/26/1996US5578714 DNA encoding Duffy 9pd protein
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578707 Soluble interferon-gamma receptor fragment
11/26/1996US5578705 Cytoplasmic antiproteinase-2 coding sequences
11/26/1996US5578704 Bone disorders
11/26/1996US5578703 Dimer proteins which bind to transforming growth factor
11/26/1996US5578701 ppRB110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product
11/26/1996US5578637 Methods of inhibition or killing cancer cells using an endoperoxide
11/26/1996US5578608 Hiv protease inhibitor
11/26/1996US5578594 Anticoagulants
11/26/1996US5578593 Releasing growth hormones for animals
11/26/1996US5578576 Nutrient solution for reducing side effects of nonsteroidal antiinflammatory drugs
11/26/1996US5578575 Septic shock
11/26/1996US5578574 Thrombin inhibitors or anticoagulants
11/26/1996US5578572 Anti-gram-positive bacterial methods and materials
11/26/1996US5578571 Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
11/26/1996US5578570 Method of treating septic shock using thymosin β4
11/26/1996US5578569 Method of increasing bone growth
11/26/1996US5578568 Method of treating conditions associated with intestinal ischemia/reperfusion
11/26/1996US5578567 Nasal pharmaceutical composition
11/26/1996US5578566 KGF receptor-derived antagonists of KGF binding
11/26/1996US5578565 Reconstituted platelet membrane vesicles
11/26/1996US5578564 Nickel-free hemoglobin and methods for producing such hemoglobin
11/26/1996US5578496 Detection of autoantibodies associated with the disease myasthenia gravis
11/26/1996US5578493 Protein codes, dna molecules, genomes, rna and genetic vectors
11/26/1996US5578484 For detection of prostate cancer
11/26/1996US5578483 Receptor transcription-repression activity compositions and methods
11/26/1996US5578482 Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
11/26/1996US5578477 Screening for anticancer drugs, source of pure enzyme
11/26/1996US5578462 NF2 isoforms
11/26/1996US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens
11/26/1996US5578451 Detecting behavior toward amyloid precursor protein
11/26/1996US5578324 Peptide proteinaceous drug nasal powder composition
11/26/1996US5578323 Proteinoid carriers and methods for preparation and use thereof
11/26/1996US5578310 Topical bioadhesive ointment compositions and their use in wound healing
11/26/1996US5578306 Method for preventing embryo implantation
11/26/1996US5578305 Methods and preparations for preventing adhesions to organs and parts of organs
11/26/1996US5578304 Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
11/26/1996US5578303 Vaccines, t-cells with specificity for heat shock protein 65
11/26/1996US5578301 Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
11/26/1996US5578300 Antiallergens for skin disorders using hydrogen peroxide
11/26/1996US5578289 Administering antibody-enzyme conjugate
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/26/1996CA2033448C Antiherpes compositions and method of use
11/21/1996WO1996036738A1 Inhibition of immune responses by paramyxovirus
11/21/1996WO1996036732A1 Methods for producing and analyzing biopolymer ladders
11/21/1996WO1996036730A1 Cell death protein
11/21/1996WO1996036720A1 Recombinant heregulins and their biological functions upon receptor activation
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036711A2 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression
11/21/1996WO1996036710A1 Bmp-15 compositions
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036708A1 Autoantigen which can be used to detect a tendency to thrombosis
11/21/1996WO1996036707A1 CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF
11/21/1996WO1996036705A1 Viral vectors
11/21/1996WO1996036704A1 Methods of use of phthalocyanines to inactivate blood borne parasites
11/21/1996WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
11/21/1996WO1996036695A1 Ataxia-telangiectasia gene
11/21/1996WO1996036691A1 Ataxia-telangiectasia gene and its genomic organization
11/21/1996WO1996036644A1 Obesity gene product
11/21/1996WO1996036643A1 Method of inhibiting restenosis using calreticulin
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036361A1 Dna binding antibodies
11/21/1996WO1996036360A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies
11/21/1996WO1996036359A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996WO1996036358A1 Compositions and methods for inhibiting xenograft rejection
11/21/1996WO1996036357A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996WO1996036356A1 Viral agent associated with mystery swine disease
11/21/1996WO1996036353A1 Method for deriving ribozymes from nucleotide sequences and ribozymes derived thereof
11/21/1996WO1996036352A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers
11/21/1996WO1996036351A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996WO1996036350A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996WO1996036349A1 POST-TRANSLATIONAL ACTIVATION OF TGF-β1 INVOLVING THE TSP-1 RECEPTOR CD36
11/21/1996WO1996036348A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
11/21/1996WO1996036317A1 Production scale method of forming microparticles
11/21/1996WO1996036314A2 Method for drug delivery to the pulmonary system
11/21/1996WO1996036227A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/21/1996WO1996033414A3 Compounds and methods for diagnosis of leishmaniasis
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection
11/21/1996WO1996029407A3 Cellubrevin homologs
1 ... 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 ... 3163